Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1508838
                    [Title] => License of nurse who reused syringes for flu shots suspended
                    [Summary] => 
A nurse accused of reusing syringes while giving flu shots to 67 patients at a pharmaceutical company in New Jersey has had her license temporarily suspended.

                    [DatePublished] => 2015-10-08 10:22:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => http://media.philstar.com/images/banat/balita/20150216/Syringes-injection.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 908491
                    [Title] => Tolvaptan effective for hyponatremia for patients with heart failure — trials
                    [Summary] => 
Tolvaptan, a new vasopressin V2-receptor antagonist and the first and only oral drug in its class, has been shown in clinical trials to be an effective treatment for hypervolemic and euvolemic hyponatremia, especially for patients with heart failure, cirrhosis, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

                    [DatePublished] => 2013-02-14 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 552301
                    [Title] => Otsuka: Reaching Milestones in health care
                    [Summary] => 
In shielding millions of people from ill health, one company stands out in its unbroken tradition of creativity, the drive to be first and best in class, and the passion to make a difference.
                    [DatePublished] => 2010-02-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 360232
                    [Title] => PAD awareness campaign launched
                    [Summary] => Are you having leg pains when walking or coldness of one extremity accompanied by a change in color? Watch out! You might have peripheral arterial disease (PAD) which, if untreated, might lead to serious complications, including leg amputation.


In a continuing commitment to the Filipino patient, Otsuka Pharmaceutical recently launched the Improve Peripheral Arterial Disease Awareness


Club (i-PAD), a project which aims to aid doctors diagnose PAD, especially among diabetic patients.  


                    [DatePublished] => 2006-09-28 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

OTSUKA PHARMACEUTICAL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1508838
                    [Title] => License of nurse who reused syringes for flu shots suspended
                    [Summary] => 
A nurse accused of reusing syringes while giving flu shots to 67 patients at a pharmaceutical company in New Jersey has had her license temporarily suspended.

                    [DatePublished] => 2015-10-08 10:22:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => http://media.philstar.com/images/banat/balita/20150216/Syringes-injection.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 908491
                    [Title] => Tolvaptan effective for hyponatremia for patients with heart failure — trials
                    [Summary] => 
Tolvaptan, a new vasopressin V2-receptor antagonist and the first and only oral drug in its class, has been shown in clinical trials to be an effective treatment for hypervolemic and euvolemic hyponatremia, especially for patients with heart failure, cirrhosis, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

                    [DatePublished] => 2013-02-14 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 552301
                    [Title] => Otsuka: Reaching Milestones in health care
                    [Summary] => 
In shielding millions of people from ill health, one company stands out in its unbroken tradition of creativity, the drive to be first and best in class, and the passion to make a difference.
                    [DatePublished] => 2010-02-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 360232
                    [Title] => PAD awareness campaign launched
                    [Summary] => Are you having leg pains when walking or coldness of one extremity accompanied by a change in color? Watch out! You might have peripheral arterial disease (PAD) which, if untreated, might lead to serious complications, including leg amputation.


In a continuing commitment to the Filipino patient, Otsuka Pharmaceutical recently launched the Improve Peripheral Arterial Disease Awareness


Club (i-PAD), a project which aims to aid doctors diagnose PAD, especially among diabetic patients.  


                    [DatePublished] => 2006-09-28 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

License of nurse who reused syringes for flu shots suspended

October 8, 2015 - 10:22am

A nurse accused of reusing syringes while giving flu shots to 67 patients at a pharmaceutical company in New Jersey has had...

World

Tolvaptan effective for hyponatremia for patients with heart failure — trials

February 14, 2013 - 12:00am

Tolvaptan, a new vasopressin V2-receptor antagonist and the first and only oral drug in its class, has been shown in clinical trials to be an effective treatment for hypervolemic and euvolemic hyponatremia, especially...

Science and Environment

Otsuka: Reaching Milestones in health care

February 25, 2010 - 12:00am

In shielding millions of people from ill health, one company stands out in its unbroken tradition of creativity, the drive to be first and best in class, and the passion to make a difference.

Science and Environment

PAD awareness campaign launched

September 28, 2006 - 12:00am

Are you having leg pains when walking or coldness of one extremity accompanied by a change in color? Watch out! You might have peripheral arterial disease (PAD) which, if untreated, might lead to serious complications,...

Science and Environment